Page URL: https://www.bionews.org.uk/page_2519

CRISPR/Cas9

A genome-editing platform that uses an enzyme (Cas9) to make a double-stranded break at a specific location in the genome, directed by a guide RNA.

Articles using this Glossary Item

Page 1 of 10
Book Review: The Code Breaker – Jennifer Douda, gene editing and the future of the human race 14 June 2021 Review
Book Review: CRISPR People – The science and ethics of editing humans 1 June 2021 Review
Machine learning technique detects epigenetic drivers of cancers 17 May 2021 News
Potential genetic target for leukaemia treatment identified 10 May 2021 News
Retron genome editing approach is faster and easier than CRISPR 10 May 2021 News
CRISPR genome editing corrects a Duchenne muscular dystrophy deletion mutation in mice 4 May 2021 News
New algorithm developed to improve personalised cancer therapy 4 May 2021 News
Podcast Review: A Brief History of CRISPR – How we learned to edit the genome 4 May 2021 Review
New CRISPR-based gene therapy for single-gene conditions 26 April 2021 News
New genetic drug target for treatment resistant colorectal cancer 19 April 2021 News
Novel CRISPR approach uses an on-off switch for epigenome editing 19 April 2021 News
Researchers warn of unintended effects from CRISPR genome editing 19 April 2021 News
CRISPR gene therapy for sickle cell disease approved by the FDA 12 April 2021 News
Genome editing 'toolkit' to speed up gene therapy development 12 April 2021 News
ORION public dialogue on genome editing 29 March 2021 Comment
Event Review: Curing the Incurable – The promises of genome editing 15 March 2021 Review
TALENs outperforms CRISPR/Cas9 in editing compact DNA 1 February 2021 News
CRISPR shown to dampen gene activity in bacteria 25 January 2021 News
Genome editing delays ageing in mice 25 January 2021 News
Monkey HIV cut from host DNA by CRISPR 7 December 2020 News
Page 1 of 10

Events using this Glossary Item

Page 1 of 0